本文へスキップ
JP

Global

Southeast Asia

Latin America

Middle East & South Asia

BIOSPHERE-AI一つの植物、東方の使命。
お問い合わせする

Knowledge graph

安全评估

概念Machine-extracted欧盟法规要求

Back to graph

検索インデックスは中国語と英語のみ対応しています。英語名または INCI 名でご検索ください。

Two sources, labelled separately on every card. Entries marked "From classical texts" come from public-domain Chinese medical classics; herbs are listed without dosages and compositions follow the common editions. Entries marked "Machine-extracted" are derived by a model from BIOSPHERE own-corpus material (formulation library, ingredient dossiers, compliance index, product catalogue). Neither is an efficacy claim or regulatory text — regulatory and safety conclusions follow the official texts and third-party test reports.

From classical textsSite dossierMachine-extractedA hyperedgeTap a circle to open that entity. Drag to pan, wheel or +/- to zoom. A square is one hyperedge joined to all of its participants.

Relations it takes part in

  1. 合规Machine-extracted6 participants

    欧盟法规合规

    常规使用方向需完成安全评估与成分申报，须明确非活菌属性与灭活工艺，以最新官方文本为准

  2. 法规Machine-extracted6 participants

    谷维素法规口径

    谷维素在中国按原料目录收录情况与备案资料要求复核，在欧盟按成品安全评估与INCI标注执行

  3. 法规Machine-extracted6 participants

    白芍提取物法规口径

    白芍提取物在中国作为化妆品原料属常规使用方向需核对收录状态与使用部位，在欧盟按成品安全评估与INCI标注执行

  4. 协议Machine-extracted6 participants

    法规合规要求

    欧盟法规要求完成安全评估与成分申报，共生发酵体系须提供菌株与工艺说明

  5. 法规评估Machine-extracted4 participants

    欧盟法规-安全评估与限制清单复核

    欧盟法规要求进行安全评估并复核植物提取物限制清单

Want to know how one of these relations plays out in your target market? Send us the formulation direction. Send an inquiry